Clinical Trial: Study on the effect and mechanism of FGF23 regulating D-serine metabolism to promote auditory impairment in chronic renal failure (China)

China, Sept. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the effect and mechanism of FGF23 regulating D-serine metabolism to promote auditory impairment in chronic renal failure'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131479

Registration Time: 2026/09/02

Type: Observational study

Primary Sponsor: First Affiliated Hospital of Kunming Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=326305

Published by HT Digital Content Services with permission from Health Daily Digest....